Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.5150 (-2.74%) ($8.4700 - $8.5150) on Thu. Jul. 27, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.79% (three month average) | RSI | 56 | Latest Price | $8.5150(-2.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(67%) ARKG(64%) IBB(57%) IWC(50%) ARKK(48%) | Factors Impacting EDIT price | EDIT will decline at least -2.395% in a week (0% probabilities). TBT(-24%) UUP(-14%) VXX(-5%) VIXM(-4%) EDOC(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.395% (StdDev 4.79%) | Hourly BBV | -2.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.64 | 5 Day Moving Average | $8.71(-2.24%) | 10 Day Moving Average | $8.71(-2.24%) | 20 Day Moving Average | $8.64(-1.45%) | To recent high | -25.9% | To recent low | 8% | Market Cap | $529m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |